LXRX Projected Dividend Yield
Lexicon Pharmaceuticals, Inc. ( NASDAQ : LXRX )Lexicon Pharmaceuticals is a biopharmaceutical company. Co. discovers the functions and pharmaceutical utility of genes and uses those gene function discoveries in the discovery and development of pharmaceutical products for the treatment of human disease. Co. is also developing sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes. Co. is developing LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain. In addition, Co. is conducting preclinical research and development and preparing to conduct clinical development of compounds from several additional drug programs. 20 YEAR PERFORMANCE RESULTS |
LXRX Dividend History Detail LXRX Dividend News LXRX Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |